Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia
Clinical trial NCT07120607 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07120607
- Sponsor
- Anhui Provincial Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2026-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.